COGT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $31.02

Market Cap (MRQ) $5.32B

P/E -14.4

EPS $-2.16

ROE -83.1%

52W Range $14–$44

COGT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1

Ex-date	Split	Type
Nov. 9, 2020	1-for-4	Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue·

2017-12-31 → 2020-12-31

EPS$-2.16

2021-12-31 → 2025-12-31

Free Cash Flow$-266M

2018-12-31 → 2025-12-31

Net margin·

2018-12-31 → 2020-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	COGT	5Y avg	Peer Median	Verdict
P/E	-14.45Y avg ≈-7.0	≈-7.0	·	·
P/S	215.65Y avg ≈71.4	≈71.4	60.4	Overvalued
P/B (MRQ)	10.05Y avg ≈3.8	≈3.8	9.3	Pricier
Price / FCF (TTM)	-17.25Y avg ≈-8.3	≈-8.3	·	·
Price / Cash Flow (TTM)	-17.35Y avg ≈-8.5	≈-8.5	·	·
Price / Tangible Book	7.85Y avg ≈3.8	≈3.8	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	5Y trend	COGT	5Y avg	Peer Median	Verdict
ROA		-52.0%5Y avg ≈-55.4%	≈-55.4%	-22.3%	Weak
ROE		-83.1%5Y avg ≈-65.6%	≈-65.6%	-35.2%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	COGT	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		13.65Y avg ≈9.9	≈9.9	9.6	Strong liquidity
Quick Ratio		4.95Y avg ≈5.2	≈5.2	5.0	Low liquidity

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	COGT	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-2.165Y avg ≈$-1.93	≈$-1.93	·	·
Cash Flow / Share	$-2.055Y avg ≈$-2.00	≈$-2.00	·	·
Cash / Share	$1.945Y avg ≈$2.09	≈$2.09	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 2.0%

Next Report Nov 02, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 11, 2026	$-0.52	$-0.58	10.5%
March 31, 2026	May 12, 2026	$-0.60	$-0.55	-8.8%
Dec. 31, 2025		$-0.64	$-0.53	-20.9%
Sept. 30, 2025		$-0.50	$-0.54	7.1%
June 30, 2025		$-0.53	$-0.60	11.4%
March 31, 2025		$-0.52	$-0.60	12.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 14

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	·	·	·	·	·	$8M	$22M	$10M	$8M
R&D Expense	$270M	$233M	$174M	$122M	$56M	$26M	$44M	$38M	$30M
SG&A Expense	$64M	$43M	$34M	$26M	$20M	$17M	$11M	$7M	$5M
Operating Expenses	$333M	$276M	$208M	$148M	$76M	$90M	$55M	$46M	$35M
Operating Income	$-333M	$-276M	$-208M	$-148M	$-76M	$-82M	$-32M	$-36M	$-26M
Interest Income	$15M	$18M	$13M	$4M	$467.0K	$144.0K	$267.0K	$1M	$386.0K
Other Non-op	$-20.0K	$2M	$943.0K	$2M	$3M	$7M	$345.0K	$320.0K	$274.0K
Income Tax	$0	·	·	·	·	·	·	·	·
Net Income	$-329M	$-256M	$-192M	$-140M	$-72M	$-75M	$-32M	$-35M	$-25M
EPS (Basic)	$-2.16	$-1.94	$-1.94	$-1.73	$-1.87	·	·	·	·
EPS (Diluted)	$-2.16	$-1.94	$-1.94	$-1.73	$-1.87	·	·	·	·
Shares (Basic)	128,899,408	103,856,611	79,657,942	58,739,713	38,730,813	·	·	·	·
Shares (Diluted)	128,899,408	103,856,611	79,657,942	58,739,713	38,730,813	·	·	·	·
EBITDA	$-333M	$-276M	$-208M	$-148M	$-76M	$-82M	$-32M	$-36M	·

Balance Sheet 22

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$312M	$98M	$53M	$140M	$220M	$242M	$37M	$56M	$28M
Short-term Investments	·	·	·	·	·	·	·	$23M	$13M
Receivables	·	·	·	·	·	·	$2M	$2M	$830.0K
Prepaid Expense	$10M	$9M	$5M	$4M	$3M	$3M	$1M	$740.0K	$513.0K
Current Assets	$910M	$296M	$271M	$265M	$223M	$245M	$41M	$81M	$42M
PP&E (Net)	$5M	$6M	$8M	$8M	$2M	$134.0K	$2M	$3M	$4M
PP&E (Gross)	$14M	$13M	$12M	$9M	$2M	$546.0K	$6M	$7M	$6M
Accum. Depreciation	$9M	$6M	$4M	$1M	$559.0K	$412.0K	$5M	$3M	$2M
Other Non-current Assets	$3M	$5M	$5M	$5M	$4M	·	$427.0K	$419.0K	·
Total Assets	$938M	$328M	$313M	$301M	$232M	$251M	$49M	$86M	$49M
Accounts Payable	$10M	$12M	$11M	$6M	$3M	$732.0K	$3M	$2M	$1M
Current Liabilities	$64M	$56M	$38M	$27M	$17M	$13M	$13M	$25M	$11M
Capital Leases	$14M	$16M	$17M	$18M	$831.0K	$3M	$4M	·	·
Other Non-current Liabilities	$33.0K	$0	·	·	·	·	·	·	·
Total Liabilities	$301M	$72M	$56M	$45M	$18M	$16M	$18M	$26M	$21M
Long-term Debt	$223M	·	·	·	·	·	·	·	·
Common Stock	$161.0K	$110.0K	$86.0K	$70.0K	$44.0K	$32.0K	$8.0K	$30.0K	$10.0K
Retained Earnings	$-1.19B	$-859M	$-604M	$-411M	$-271M	$-199M	$-124M	$-92M	$-51M
AOCI	$355.0K	$447.0K	$246.0K	$-104.0K	·	·	·	$-12.0K	$-16.0K
Stockholders' Equity	$636M	$256M	$258M	$256M	$214M	$235M	$32M	$60M	$-49M
Liabilities + Equity	$938M	$328M	$313M	$301M	$232M	$251M	$49M	$86M	$49M
Shares Outstanding	160,980,024	110,461,729	86,124,249	69,893,434	43,805,922	32,347,905	7,665,763	30,057,970	10,201,690

Cash Flow 15

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$3M	$2M	$2M	$800.0K	$147.0K	$720.0K	$1M	$1M	$1M
Stock-based Comp	$46M	$40M	$31M	$18M	$12M	$6M	$3M	$3M	$1M
Deferred Tax	$0	$0	$0	$0	$0	$0	$0	$0	$0
Restructuring	·	·	·	·	·	$4M	·	·	·
Operating Cash Flow	$-264M	$-208M	$-154M	$-119M	$-59M	$-36M	$-42M	$-32M	$-26M
CapEx	$2M	$573.0K	$3M	$7M	$2M	·	$33.0K	$549.0K	$912.0K
Investing Cash Flow	$-400M	$38M	$-98M	$-125M	$-2M	$8M	$23M	$-11M	$14M
Debt Issued	$49M	$0	$0	·	·	·	·	·	·
Net Debt Issued	$49M	·	·	·	·	·	·	·	·
Stock Issued	·	$0	$162M	$0	$0	$25M	$108.0K	$609.0K	$60.0K
Net Stock Activity	·	$0	$162M	·	·	$25M	$108.0K	$609.0K	·
Financing Cash Flow	$878M	$214M	$164M	$164M	$38M	$232M	$108.0K	$70M	$-729.0K
Net Change in Cash	$214M	$45M	$-88M	$-80M	$-23M	$205M	$-18M	$27M	$-13M
Taxes Paid	$0	·	·	·	·	·	·	·	·
Free Cash Flow	$-266M	$-208M	$-156M	$-126M	$-60M	·	$-42M	$-33M	·

Profitability 5

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	·	·	·	·	·	-1044.3%	-143.0%	-369.9%	·
Net Margin	·	·	·	·	·	-950.4%	-141.5%	-354.8%	·
EBITDA Margin	·	·	·	·	·	-1044.3%	-143.0%	-369.9%	·
ROA	-52.0%	-79.8%	-62.6%	-52.6%	-29.9%	-49.8%	-47.0%	-51.1%	·
ROE	-83.1%	-89.6%	-68.6%	-51.4%	-35.1%	-70.4%	-105.4%	-54.1%	·

Liquidity & Solvency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio		14.2	5.3	7.1	9.9	13.0	18.7	3.1	3.2	·
Quick Ratio		4.9	1.8	1.4	5.2	12.9	18.5	3.0	3.2	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover		·	·	·	·	·	0.1	0.3	0.1	·
Receivables Turnover		·	·	·	·	·	·	12.3	7.8	·

Per Share 4

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$3.95	$2.32	$2.99	$3.66	$4.89	$7.25	$1.04	$2.00	·
Cash Flow / Share	$-2.05	$-2.00	$-1.93	$-2.02	·	·	·	·	·
Cash / Share	$1.94	$0.89	$0.62	$2.00	$5.01	$7.49	$1.22	$1.85	·
EPS (TTM)	$-2.16	$-1.94	$-1.94	$-1.73	$-1.87	$-1.05	$-1.05	$-1.60	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$23M	$23M	$23M	$23M	$23M	$8M	$22M	$10M	·
Net Income TTM	$-329M	$-256M	$-192M	$-140M	$-72M	$-75M	$-32M	$-35M	·
Market Cap	$5.72B	$862M	$506M	$808M	$376M	$363M	$88M	$529M	·
P/E	-16.4	-4.0	-3.0	-6.7	-4.6	-10.7	-2.7	-11.0	·
P/S	246.9	37.2	21.9	34.9	16.2	46.2	3.9	54.3	·
P/B	9.0	3.4	2.0	3.2	1.8	1.5	2.8	8.8	·
P / Tangible Book	9.0	3.4	2.0	3.2	1.8	1.5	·	·	·
P / Cash Flow	-21.6	-4.1	-3.3	-6.8	-6.4	-10.1	-2.1	-16.3	·
P / FCF	-21.5	-4.1	-3.2	-6.4	-6.2	·	-2.1	-16.0	·
Earnings Yield	-6.1%	-24.9%	-33.0%	-15.0%	-21.8%	-9.3%	-36.5%	-9.1%	·

Income Statement 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
R&D Expense	$71M	$75M	$76M	$69M	$62M	$63M	$62M	$64M	$54M	$53M	$50M	$39M	$36M	$30M	$29M	$25M
SG&A Expense	$32M	$28M	$24M	$14M	$13M	$12M	$12M	$12M	$10M	$10M	$9M	$8M	$7M	$7M	$6M	$6M
Operating Expenses	$103M	$104M	$99M	$83M	$76M	$75M	$74M	$75M	$64M	$62M	$60M	$47M	$43M	$37M	$36M	$31M
Operating Income	$-103M	$-104M	$-99M	$-83M	$-76M	$-75M	$-74M	$-75M	$-64M	$-62M	$-60M	$-47M	$-43M	$-37M	$-36M	$-31M
Interest Income	$7M	$8M	$5M	$4M	$2M	$3M	$4M	$5M	$5M	$4M	$4M	$3M	$2M	$2M	$272.0K	$107.0K
Other Non-op	$-11.0K	$-140.0K	$-6.0K	$-3.0K	$-6.0K	$-5.0K	$2M	$1.0K	$44.0K	$-1.0K	$0	$268.0K	$682.0K	$2M	$928.0K	$784.0K
Net Income	$-96M	$-97M	$-102M	$-81M	$-74M	$-72M	$-68M	$-71M	$-59M	$-58M	$-55M	$-44M	$-39M	$-35M	$-35M	$-31M
EPS (Basic)	$-0.52	$-0.53	$-0.61	$-0.50	$-0.53	$-0.52	$-0.50	$-0.52	$-0.43	$-0.49	$-0.64	$-0.59	$-0.55	$-0.50	$-0.71	$-0.68
EPS (Diluted)	$-0.52	$-0.53	$-0.61	$-0.50	$-0.53	$-0.52	$-0.50	$-0.52	$-0.43	$-0.49	$-0.64	$-0.59	$-0.55	$-0.50	$-0.71	$-0.68
Shares (Basic)	171,005,468	162,194,778	·	137,550,159	114,466,080	113,307,940	·	110,165,580	99,240,030	94,804,659	86,165,951	74,753,269	70,734,950	69,576,359	49,388,936	45,105,923
Shares (Diluted)	171,005,468	162,194,778	·	137,550,159	114,466,080	113,307,940	·	110,165,580	99,240,030	94,804,659	86,165,951	74,753,269	70,734,950	69,576,359	49,388,936	45,105,923
EBITDA	$-103M	$-104M	·	$-83M	$-76M	$-75M	·	$-75M	$-64M	$-62M	$-60M	$-47M	$-43M	$-37M	$-36M	$-31M

Balance Sheet 21

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$181M	$241M	$312M	$125M	$128M	$126M	$98M	$97M	$88M	$216M	$87M	$214M	$161M	$141M	$326M	$191M
Prepaid Expense	$13M	$11M	$10M	$6M	$7M	$7M	$9M	$6M	$7M	$6M	$7M	$5M	$5M	$6M	$4M	$4M
Current Assets	$805M	$878M	$910M	$397M	$245M	$253M	$296M	$342M	$370M	$442M	$286M	$335M	$226M	$296M	$331M	$195M
PP&E (Net)	$5M	$5M	$5M	$5M	$6M	$6M	$6M	$7M	$7M	$8M	$9M	$9M	$9M	$7M	$4M	$2M
PP&E (Gross)	·	·	$14M	·	·	·	$13M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$9M	·	·	·	$6M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$2M	$2M	$3M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$6M
Total Assets	$835M	$903M	$938M	$426M	$275M	$284M	$328M	$384M	$430M	$476M	$355M	$392M	$263M	$332M	$366M	$207M
Accounts Payable	$7M	$14M	$10M	$16M	$17M	$14M	$12M	$15M	$9M	$16M	$10M	$7M	$4M	$4M	$3M	$4M
Current Liabilities	$59M	$58M	$64M	$62M	$58M	$49M	$56M	$53M	$40M	$37M	$35M	$26M	$21M	$24M	$28M	$18M
Capital Leases	$19M	$14M	$14M	$15M	$15M	$15M	$16M	$16M	$17M	$17M	$18M	$18M	$19M	$18M	$19M	$1M
Other Non-current Liabilities	$90.0K	$62.0K	$33.0K	$2M	$2M	$5.0K	$0	·	·	·	·	·	·	·	·	·
Total Liabilities	$302M	$295M	$301M	$123M	$120M	$65M	$72M	$69M	$57M	$54M	$53M	$44M	$40M	$42M	$47M	$19M
Long-term Debt	$223M	$223M	$223M	$44M	$44M	·	·	·	·	·	·	·	·	·	·	·
Total Debt	·	·	·	$44M	$44M	·	·	·	·	·	·	·	·	·	·	·
Common Stock	$171.0K	$171.0K	$161.0K	$141.0K	$114.0K	$114.0K	$110.0K	$110.0K	$109.0K	$96.0K	$86.0K	$85.0K	$71.0K	$70.0K	$66.0K	$46.0K
Retained Earnings	$-1.38B	$-1.29B	$-1.19B	$-1.09B	$-1.00B	$-931M	$-859M	$-792M	$-721M	$-662M	$-549M	$-494M	$-450M	$-372M	$-337M	$-302M
AOCI	$-770.0K	$-415.0K	$355.0K	$208.0K	$13.0K	$164.0K	$447.0K	$896.0K	$-192.0K	$-39.0K	$-172.0K	$-97.0K	$16.0K	$-163.0K	·	·
Stockholders' Equity	$532M	$608M	$636M	$302M	$155M	$219M	$256M	$315M	$373M	$422M	$303M	$348M	$224M	$290M	$319M	$188M
Liabilities + Equity	$835M	$903M	$938M	$426M	$275M	$284M	$328M	$384M	$430M	$476M	$355M	$392M	$263M	$332M	$366M	$207M
Shares Outstanding	171,598,409	170,773,803	160,980,024	139,827,662	113,928,492	113,856,454	110,461,729	110,458,249	109,343,224	95,613,396	86,124,249	85,334,165	70,946,790	69,857,972	65,707,714	45,819,266

Cash Flow 10

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
D&A	$741.0K	$626.0K	$664.0K	$641.0K	$655.0K	$640.0K	$675.0K	$620.0K	$606.0K	$599.0K	$581.0K	$562.0K	$529.0K	$256.0K	$97.0K	$69.0K
Stock-based Comp	$17M	$17M	$16M	$11M	$10M	$10M	$10M	$10M	$10M	$9M	$9M	$7M	$6M	$5M	$5M	$4M
Operating Cash Flow	$-77M	$-87M	$-79M	$-64M	$-55M	$-67M	$-61M	$-52M	$-43M	$-53M	$-38M	$-32M	$-40M	$-34M	$-26M	$-28M
CapEx	$370.0K	$449.0K	$811.0K	$65.0K	$131.0K	$547.0K	$75.0K	$280.0K	$148.0K	$70.0K	$121.0K	$1M	$1M	$3M	$1M	$441.0K
Investing Cash Flow	$14M	$-36M	$-323M	$-155M	$9M	$69M	$62M	$60M	$-85M	$1M	$-91M	$-78M	$60M	$-152M	$-1M	$-441.0K
Debt Issued	·	·	$0	$0	·	·	·	·	·	·	·	·	·	·	·	·
Stock Issued	·	·	·	·	·	·	·	$0	·	·	$-170.0K	·	·	·	·	·
Financing Cash Flow	$3M	$53M	$589M	$217M	$47M	$25M	$26.0K	$624.0K	$-256.0K	$214M	$1M	$162M	$445.0K	$990.0K	$162M	$138.0K
Net Change in Cash	$-60M	$-71M	$187M	$-2M	$2M	$28M	$1M	$9M	$-128M	$163M	$-128M	$52M	$21M	$-185M	$135M	$-29M
Free Cash Flow	·	$-87M	·	·	·	$-67M	·	·	·	$-53M	·	·	$-41M	·	·	$-29M

Profitability 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
ROA		-17.4%	-16.4%	·	-20.0%	-20.9%	-18.9%	·	-19.1%	-14.3%	-15.8%	-16.1%	-11.6%	-16.4%	-12.8%	-11.8%	-13.8%
ROE		-28.1%	-23.5%	·	-26.2%	-27.8%	-22.4%	·	-22.9%	-16.3%	-18.1%	-18.7%	-13.2%	-18.8%	-14.4%	-13.1%	-14.8%

Liquidity & Solvency 4

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio	13.6	15.1	·	6.4	4.2	5.1	·	6.4	9.2	12.0	8.2	13.0	10.7	12.6	12.0	10.9
Quick Ratio	3.1	4.2	·	2.0	2.2	2.6	·	1.8	2.2	5.9	2.5	8.3	7.6	6.0	11.8	10.7
Debt / Equity	·	·	·	0.1	0.3	·	·	·	·	·	·	·	·	·	·	·
LT Debt / Equity	·	·	·	0.1	0.3	·	·	·	·	·	·	·	·	·	·	·

Per Share 4

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$3.10	$3.56	·	$2.16	$1.36	$1.92	·	$2.85	$3.41	$4.42	$3.52	$4.08	$3.15	$4.15	$4.86	$4.10
Cash Flow / Share	·	$-0.54	·	·	·	$-0.59	·	·	·	$-0.55	·	·	$-0.56	·	·	·
Cash / Share	$1.06	$1.41	·	$0.90	$1.12	$1.11	·	$0.88	$0.81	$2.26	$1.01	$2.51	$2.27	$2.01	$4.95	$4.17
EPS (TTM)	$-2.16	$-2.17	·	$-2.05	$-2.07	$-1.97	·	$-1.60	$-1.72	$-1.88	$-1.62	$-1.48	$-1.60	$-2.51	$-2.49	$-2.21

Valuation (TTM) 11

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$8M	$8M	·	$8M	$8M	$8M	·	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M
Net Income TTM	$-377M	$-354M	·	$-294M	$-284M	$-269M	·	$-242M	$-227M	$-212M	$-178M	$-157M	$-148M	$-126M	$-110M	$-91M
Market Cap	$6.64B	$6.57B	·	$2.01B	$818M	$682M	·	$1.19B	$922M	$643M	$840M	$1.01B	$766M	$1.04B	$593M	$343M
Enterprise Value	·	·	·	$1.93B	$734M	·	·	·	·	·	·	·	·	·	·	·
P/E	-17.9	-17.7	·	-7.0	-3.5	-3.0	·	-6.8	-4.9	-3.6	-6.0	-8.0	-6.7	-5.9	-3.6	-3.4
P/S	843.7	835.1	·	255.1	103.9	86.6	·	151.6	117.1	81.6	106.7	128.4	97.3	132.4	75.3	43.6
P/B	12.5	10.8	·	6.6	5.3	3.1	·	3.8	2.5	1.5	2.8	2.9	3.4	3.6	1.9	1.8
P / Tangible Book	12.5	10.8	·	6.6	5.3	3.1	·	3.8	2.5	1.5	2.8	2.9	3.4	3.6	1.9	1.8
P / Cash Flow	·	-75.7	·	·	·	-10.3	·	·	·	-12.2	·	·	-19.4	·	·	-12.1
EV / Revenue	·	·	·	244.8	93.3	·	·	·	·	·	·	·	·	·	·	·
Earnings Yield	-5.6%	-5.6%	·	-14.3%	-28.8%	-32.9%	·	-14.8%	-20.4%	-28.0%	-16.6%	-12.5%	-14.8%	-16.8%	-27.6%	-29.5%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Net Income	$-329M	$-256M	$-192M	$-140M	$-72M
Diluted EPS	$-2.16	$-1.94	$-1.94	$-1.73	$-1.87

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Current Ratio	14.2	5.3	7.1	9.9	13.0
Quick Ratio	4.9	1.8	1.4	5.2	12.9

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-266M	$-208M	$-156M	$-126M	$-60M

Institutional owners (13F) 340 filers · $7.6B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 340

Value held $7.6B

New positions 65

Exited positions 41

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
65 (-17 vs prior Q)	41 (+7 vs prior Q)	133 (+15 vs prior Q)	90 (+9 vs prior Q)	+3.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
FMR LLC	$993,861,419	25,681,174	13.11%	Shares
BlackRock, Inc.	$671,547,401	17,352,646	8.86%	Shares
VANGUARD GROUP INC	$408,988,860	11,514,326	5.40%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$312,402,306	8,072,411	4.12%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$286,857,171	7,412,330	3.78%	Shares
STATE STREET CORP	$269,542,365	6,964,919	3.56%	Shares
JANUS HENDERSON GROUP PLC	$229,633,788	5,965,125	3.03%	Shares
Fairmount Funds Management LLC	$212,982,277	5,503,418	2.81%	Shares
DEERFIELD MANAGEMENT COMPANY, L.P.	$193,736,225	5,006,104	2.56%	Shares
TCG Crossover Management, LLC	$187,866,673	4,854,436	2.48%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$174,534,880	4,508,998	2.30%	Shares
WELLINGTON MANAGEMENT GROUP LLP	$168,111,910	4,343,977	2.22%	Shares
Kynam Capital Management, LP	$141,916,654	3,667,097	1.87%	Shares
Polar Capital Holdings Plc	$125,113,424	3,232,905	1.65%	Shares
Commodore Capital LP	$118,035,000	3,050,000	1.56%	Shares
Invesco Ltd.	$100,973,759	2,609,141	1.33%	Shares
Woodline Partners LP	$100,742,369	2,603,162	1.33%	Shares
Pictet Asset Management Holding SA	$92,634,023	2,393,515	1.22%	Shares
Octagon Capital Advisors LP	$90,945,000	2,350,000	1.20%	Shares
RTW INVESTMENTS, LP	$89,359,113	2,309,021	1.18%	Shares
GOLDMAN SACHS GROUP INC	$88,570,098	2,288,633	1.17%	Shares
Candriam S.C.A.	$80,742,121	2,088,369	1.07%	Shares
Deep Track Capital, LP	$77,400,000	2,000,000	1.02%	Shares
Siren, L.L.C.	$71,954,097	1,859,279	0.95%	Shares
ORBIMED ADVISORS LLC	$65,066,310	1,681,300	0.86%	Shares
Venrock Adviser, LLC	$63,551,824	1,642,166	0.84%	Shares
EMERALD ADVISERS, LLC	$62,048,445	1,603,319	0.82%	Shares
NORTHERN TRUST CORP	$60,288,021	1,557,830	0.80%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$56,087,910	1,449,300	0.74%	Shares
Assenagon Asset Management S.A.	$55,795,957	1,441,756	0.74%	Shares
BANK OF AMERICA CORP /DE/	$55,713,759	1,439,632	0.74%	Shares
AMERICAN CENTURY COMPANIES INC	$55,455,537	1,432,957	0.73%	Shares
SILVERARC CAPITAL MANAGEMENT, LLC	$49,563,361	1,280,707	0.65%	Shares
VANGUARD FIDUCIARY TRUST CO	$46,962,837	1,213,510	0.62%	Shares
Elmind Capital, LP	$45,307,638	1,170,740	0.60%	Shares
UBS Group AG	$43,430,881	1,122,245	0.57%	Shares
FRED ALGER MANAGEMENT, LLC	$41,518,521	1,072,830	0.55%	Shares
Sofinnova Investments, Inc.	$40,060,228	1,035,148	0.53%	Shares
EMERALD MUTUAL FUND ADVISERS TRUST	$39,914,329	1,031,378	0.53%	Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$39,558,482	1,022,183	0.52%	Shares
RENAISSANCE TECHNOLOGIES LLC	$38,551,702	996,168	0.51%	Shares
Balyasny Asset Management L.P.	$36,952,424	954,843	0.49%	Shares
VOYA INVESTMENT MANAGEMENT LLC	$36,871,696	952,757	0.49%	Shares
MORGAN STANLEY	$36,444,817	941,725	0.48%	Shares
D. E. Shaw & Co., Inc.	$35,699,937	922,479	0.47%	Shares
MILLENNIUM MANAGEMENT LLC	$35,128,454	907,712	0.46%	Shares
Logos Global Management LP	$34,830,000	900,000	0.46%	Shares
Squadron Capital Management LLC	$33,475,500	865,000	0.44%	Shares
CITADEL ADVISORS LLC	$32,883,158	849,694	0.43%	Shares
Point72 Asset Management, L.P.	$28,800,347	744,195	0.38%	Shares

Show all 340 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×11 filings	March 31, 2026	8.60%	Amendment	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 25 insiders · 11 officers · 13 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Andrew R Robbins	President and CEO	May 19, 2026 G	160,000	0	$0
Charles Wilson	Chief Executive Officer	March 1, 2019 A	·	0	$0
John L. Green	Chief Financial Officer	Dec. 26, 2025 S	131,834	1	$-2,978,360
Matthew Scott Osborne	Chief Financial Officer	Feb. 11, 2020 A	·	0	$0
John Edward Robinson	Chief Scientific Officer	Dec. 26, 2025 S	140,002	1	$-3,486,600
Jessica Sachs	Chief Medical Officer	Dec. 26, 2025 S	133,938	1	$-3,198,245
Evan Kearns	Chief Legal Officer	Dec. 26, 2025 S	109,398	1	$-2,515,500
Cole Pinnow	Chief Commercial Officer	Dec. 17, 2025 A	216,650	0	$0
Geoffrey Hodge	Chief Technical Officer	Feb. 11, 2020 A	·	0	$0
Seth Ettenberg	Chief Scientific Officer	Feb. 11, 2020 A	0	0	$0
Michael Vasconcelles	Chief Medical Officer	March 1, 2019 A	·	0	$0
Arlene Morris	Director	Aug. 27, 2026 M	0	2	$-1,689,388
Karen Jean Ferrante	Director	July 1, 2026 A	·	0	$0
Christopher W. Cain	Director	June 9, 2026 A	·	0	$0
Todd Shegog	Director	June 9, 2026 A	·	0	$0
Matthew Ros	Director	June 9, 2026 A	·	0	$0
Peter Harwin	Director	June 9, 2026 A	·	0	$0
Fairmount Funds Management LLC	Director	March 31, 2026 C	5,503,418	2	$-370,020,000
Jorn Aldag	Director	July 1, 2020 A	·	0	$0
Bruce Booth	Director	July 1, 2020 A	3,361,535	0	$0
Liam Ratcliffe	Director	June 14, 2019 A	897,773	0	$0
Robert J Perez	Director	June 14, 2019 A	·	0	$0
Dario Campana	10% owner	May 12, 2020 S	3,095,114	0	$0
FIL Ltd	·	April 3, 2018 C	1,138,274	0	$0
FMR LLC	·	April 3, 2018 C	23,240	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 35 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
LABU · Direxion Shares ETF Trust	0.85%	107,533 NS	July 31, 2026	N-PORT
BBC · ETFis Series Trust I	0.79%	9,390 NS	July 31, 2026	N-PORT
JSML · Janus Detroit Street Trust	0.62%	57,786 NS	July 31, 2026	N-PORT
FDMO · FIDELITY COVINGTON TRUST	0.58%	134,513 NS	July 31, 2026	N-PORT
ESSC · Strategy Shares	0.44%	4,046 NS	July 31, 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0.38%	178,467 SH	Aug. 19, 2026	Daily
IWO · iShares Trust	0.37%	1,569,593 SH	Sept. 11, 2026	Daily
IBB · iShares Trust	0.37%	1,125,962 SH	Sept. 11, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.37%	12,272 SH	Oct. 2, 2026	Daily
FFSM · FIDELITY COVINGTON TRUST	0.25%	95,539 NS	July 31, 2026	N-PORT
PWS · Pacer Funds Trust	0.24%	1,469 NS	July 31, 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0.24%	42,273 NS	July 31, 2026	N-PORT
RSSL · Global X Funds	0.21%	79,831 NS	July 31, 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0.20%	4,588 NS	July 31, 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0.20%	959,613 SH	Aug. 19, 2026	Daily
IWM · iShares Trust	0.19%	4,260,580 SH	Sept. 11, 2026	Daily
ISCG · iShares Trust	0.17%	49,190 SH	Sept. 11, 2026	Daily
VFMO · VANGUARD WELLINGTON FUND	0.17%	85,339 SH	Aug. 19, 2026	Daily
VBR · VANGUARD INDEX FUNDS	0.13%	2,363,019 SH	Aug. 19, 2026	Daily
VB · VANGUARD INDEX FUNDS	0.08%	3,722,357 SH	Aug. 19, 2026	Daily
ESML · iShares Trust	0.07%	59,663 SH	Sept. 11, 2026	Daily
VXF · VANGUARD INDEX FUNDS	0.07%	1,958,933 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.07%	368,585 SH	Aug. 19, 2026	Daily
FHLC · FIDELITY COVINGTON TRUST	0.07%	58,328 NS	July 31, 2026	N-PORT
WSML · iShares Trust	0.04%	8,633 SH	Sept. 11, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.04%	31,254 SH	Oct. 2, 2026	Daily
TILT · FlexShares Trust	0.01%	7,426 NS	July 31, 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0.01%	5,158,077 SH	Aug. 19, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.01%	133,924 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.01%	13,697 SH	Aug. 19, 2026	Daily
ESGV · VANGUARD WORLD FUND	0.01%	36,815 SH	Aug. 19, 2026	Daily
ITOT · iShares Trust	0.01%	228,048 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.01%	44,772 SH	Sept. 10, 2026	Daily
ISCB · iShares Trust	·	6,956 SH	Sept. 11, 2026	Daily
SMLF · iShares Trust	·	19,041 SH	Sept. 11, 2026	Daily

COGT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 18 analysts BUY

Median target $55.00 +77.3%

8 44.4% Strong Buy

8 44.4% Buy

2 11.1% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

11 analysts · 2026-10-04

Mean target $55.82 +79.9%

← Below all targets Current price $31.02

Low$45.00 Mean$55.82 High$62.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
COGT	$5.72B	-16.4	·	·	-83.1%	·
GRAL	$3.45B	-7.7	17.2%	-277.5%	-16.7%	·
CGON	$3.35B	-20.0	254.7%	-3985.0%	-22.6%	·
SRRK	$4.78B	-13.4	·	·	-157.9%	·
KOD	$1.73B	-6.5	·	·	-202.0%	·
ORKA	$1.48B	-3.3	·	·	-25.9%	·
MIRM	$4.10B	-168.1	54.7%	-4.5%	-8.2%	·
TVTX	$3.47B	-131.8	110.5%	-5.2%	-34.6%	·
PTCT	$6.19B	9.8	114.5%	39.4%	-331.5%	·
ERAS	$1.06B	-8.5	·	·	-35.7%	·
DNTH	$1.78B	-9.8	-67.3%	-7973.3%	-40.8%	·

Latest News Recent headlines mentioning this company

23

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch Nasdaq · 6 months, 1 week ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

COGT Cogent Biosciences, Inc. - Common Stock